BioSpace4h
The APAC Opportunity: Why Clinical Trials Are Shifting East
APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
Taiwan News6h
Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform
In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.
Taiwan News6d
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its ...